Lifetime antipsychotic medication and cognitive performance in schizophrenia at age 43 years in a general population birth cohort

This naturalistic study analysed the association between cumulative lifetime antipsychotic dose and cognition in schizophrenia after an average of 16.5 years of illness. Sixty participants with schizophrenia and 191 controls from the Northern Finland Birth Cohort 1966 were assessed at age 43 years w...

Descrición completa

Detalles Bibliográficos
Autores principales: Husa, Anja P., Moilanen, Jani, Murray, Graham K., Marttila, Riikka, Haapea, Marianne, Rannikko, Irina, Barnett, Jennifer H., Jones, Peter B., Isohanni, Matti, Remes, Anne M., Koponen, Hannu, Miettunen, Jouko, Jääskeläinen, Erika
Formato: Online Artigo Texto
Idioma:English
Publicado: Elsevier/North-Holland Biomedical Press 2017
Materias:
Article
Acceso en liña:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5241225/
https://www.ncbi.nlm.nih.gov/pubmed/27888683
http://dx.doi.org/10.1016/j.psychres.2016.10.085

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5241225/
https://www.ncbi.nlm.nih.gov/pubmed/27888683
http://dx.doi.org/10.1016/j.psychres.2016.10.085

Títulos similares